CD86 and neoplasm: Suppressed tumor growth (Fig. 2h, i), downregulated expression of TAM immunosuppressive markers (i.e., CD206; Fig. 2j), upregulated expression of TAM immunostimulatory markers (i.e., CD69 and CD86; Fig. 2k, l) and enhanced tumor-infiltrating CD8+ T-cell reactivity (i.e., increased production of Granzyme B; Fig. 2m) were observed in mice receiving Maoa KO BMDMs.